Vasosol Organ Perfusion Solution and Medtronic Portable Bypass System
Sponsor
Polyak, Maximilian (Other)
Overall Status
Completed
CT.gov ID
NCT00879268
Collaborator
Health Resources and Services Administration (HRSA) (U.S. Fed)
20
55.1
Study Details
Study Description
Brief Summary
This is a pilot trial of centrifugal machine preservation of donor livers for transplantation using a novel preservation solution.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 1 |
Study Design
Study Type:
Interventional
Actual Enrollment
:
20 participants
Allocation:
Non-Randomized
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Phase 1 Study of Liver Machine Preservation With Vasosol Solution
Study Start Date
:
Jul 1, 2004
Actual Primary Completion Date
:
Feb 1, 2008
Actual Study Completion Date
:
Feb 1, 2009
Outcome Measures
Primary Outcome Measures
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
-
Primary/ Solitary Liver Transplant
-
Lab MELD<35
-
Donor age <65
Exclusion Criteria:
-
Donor Liver > 30% Macrosteatosis
-
DCD donor liver
-
Multi-organ Recipient
-
Recipient in ICU
-
Retransplant
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Polyak, Maximilian
- Health Resources and Services Administration (HRSA)
Investigators
- Principal Investigator: James V. Guarrera, M.D., Columbia University
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
,
,
ClinicalTrials.gov Identifier:
NCT00879268
Other Study ID Numbers:
- G030132
First Posted:
Apr 9, 2009
Last Update Posted:
Apr 9, 2009
Last Verified:
Apr 1, 2009
Keywords provided by ,
,
Additional relevant MeSH terms: